Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 5.89579993 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.89579993 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.60736590 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.60736590 |
5 | L-phenylalanine catabolic process (GO:0006559) | 5.40770043 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.40770043 |
7 | lysine metabolic process (GO:0006553) | 4.89763277 |
8 | lysine catabolic process (GO:0006554) | 4.89763277 |
9 | NADH metabolic process (GO:0006734) | 4.83370615 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70550029 |
11 | sulfur amino acid catabolic process (GO:0000098) | 4.66067427 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 4.57989387 |
13 | cellular ketone body metabolic process (GO:0046950) | 4.54166735 |
14 | tricarboxylic acid cycle (GO:0006099) | 4.52186747 |
15 | aspartate family amino acid catabolic process (GO:0009068) | 4.47279510 |
16 | kynurenine metabolic process (GO:0070189) | 4.45704959 |
17 | barbed-end actin filament capping (GO:0051016) | 4.44384396 |
18 | protein maturation by protein folding (GO:0022417) | 4.38098217 |
19 | succinate metabolic process (GO:0006105) | 4.36503040 |
20 | oxaloacetate metabolic process (GO:0006107) | 4.22757422 |
21 | amino-acid betaine metabolic process (GO:0006577) | 4.18616980 |
22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.18570625 |
23 | cysteine metabolic process (GO:0006534) | 4.17211034 |
24 | glyoxylate metabolic process (GO:0046487) | 4.15315133 |
25 | regulation of triglyceride catabolic process (GO:0010896) | 4.05516410 |
26 | pinocytosis (GO:0006907) | 4.05009392 |
27 | urea metabolic process (GO:0019627) | 4.04805217 |
28 | urea cycle (GO:0000050) | 4.04805217 |
29 | tryptophan catabolic process (GO:0006569) | 4.03999417 |
30 | indole-containing compound catabolic process (GO:0042436) | 4.03999417 |
31 | indolalkylamine catabolic process (GO:0046218) | 4.03999417 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.00868197 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.00185697 |
34 | 2-oxoglutarate metabolic process (GO:0006103) | 3.98818272 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 3.96765238 |
36 | protein localization to endosome (GO:0036010) | 3.92132242 |
37 | bile acid biosynthetic process (GO:0006699) | 3.90263027 |
38 | ketone body metabolic process (GO:1902224) | 3.86072116 |
39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.82632625 |
40 | glycosphingolipid catabolic process (GO:0046479) | 3.75273179 |
41 | alpha-amino acid catabolic process (GO:1901606) | 3.69436132 |
42 | glutamate metabolic process (GO:0006536) | 3.69222914 |
43 | regulation of cholesterol homeostasis (GO:2000188) | 3.67692129 |
44 | nitrogen cycle metabolic process (GO:0071941) | 3.67081438 |
45 | tryptophan metabolic process (GO:0006568) | 3.66543913 |
46 | acetyl-CoA metabolic process (GO:0006084) | 3.66039467 |
47 | glycolipid catabolic process (GO:0019377) | 3.65213503 |
48 | negative regulation of cholesterol transport (GO:0032375) | 3.63436223 |
49 | negative regulation of sterol transport (GO:0032372) | 3.63436223 |
50 | amyloid precursor protein catabolic process (GO:0042987) | 3.62030200 |
51 | short-chain fatty acid metabolic process (GO:0046459) | 3.61499994 |
52 | carnitine metabolic process (GO:0009437) | 3.58257445 |
53 | fatty acid beta-oxidation (GO:0006635) | 3.57551810 |
54 | regulation of cholesterol esterification (GO:0010872) | 3.56419286 |
55 | cellular amino acid catabolic process (GO:0009063) | 3.55751335 |
56 | negative regulation of fibrinolysis (GO:0051918) | 3.54444565 |
57 | fatty acid transmembrane transport (GO:1902001) | 3.52246183 |
58 | pentose-phosphate shunt (GO:0006098) | 3.51568969 |
59 | coenzyme catabolic process (GO:0009109) | 3.50552768 |
60 | homocysteine metabolic process (GO:0050667) | 3.49076732 |
61 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.48002174 |
62 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.47605430 |
63 | aromatic amino acid family metabolic process (GO:0009072) | 3.46684614 |
64 | drug catabolic process (GO:0042737) | 3.43597078 |
65 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43243623 |
66 | fatty acid catabolic process (GO:0009062) | 3.43084272 |
67 | triglyceride homeostasis (GO:0070328) | 3.42865116 |
68 | acylglycerol homeostasis (GO:0055090) | 3.42865116 |
69 | flavonoid metabolic process (GO:0009812) | 3.42085455 |
70 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.41730248 |
71 | carnitine shuttle (GO:0006853) | 3.41123149 |
72 | fructose metabolic process (GO:0006000) | 3.40242181 |
73 | bile acid metabolic process (GO:0008206) | 3.38982510 |
74 | fatty acid oxidation (GO:0019395) | 3.38085408 |
75 | reverse cholesterol transport (GO:0043691) | 3.37867574 |
76 | dicarboxylic acid catabolic process (GO:0043649) | 3.36961428 |
77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.35767153 |
78 | protein carboxylation (GO:0018214) | 3.35767153 |
79 | NAD metabolic process (GO:0019674) | 3.35497539 |
80 | lipid oxidation (GO:0034440) | 3.33768331 |
81 | monocarboxylic acid catabolic process (GO:0072329) | 3.33658809 |
82 | protein retention in ER lumen (GO:0006621) | 3.32024148 |
83 | phospholipid homeostasis (GO:0055091) | 3.31069291 |
84 | protein-lipid complex remodeling (GO:0034368) | 3.30554543 |
85 | macromolecular complex remodeling (GO:0034367) | 3.30554543 |
86 | plasma lipoprotein particle remodeling (GO:0034369) | 3.30554543 |
87 | carboxylic acid catabolic process (GO:0046395) | 3.27613252 |
88 | organic acid catabolic process (GO:0016054) | 3.27613252 |
89 | regulation of fibrinolysis (GO:0051917) | 3.24966842 |
90 | positive regulation of lipid catabolic process (GO:0050996) | 3.21055977 |
91 | NADPH regeneration (GO:0006740) | 3.20906055 |
92 | phospholipid efflux (GO:0033700) | 3.19060556 |
93 | complement activation, alternative pathway (GO:0006957) | 3.18482998 |
94 | cellular modified amino acid catabolic process (GO:0042219) | 3.17305842 |
95 | drug transmembrane transport (GO:0006855) | 3.15559541 |
96 | bile acid and bile salt transport (GO:0015721) | 3.15250966 |
97 | fatty acid homeostasis (GO:0055089) | 3.14917442 |
98 | gluconeogenesis (GO:0006094) | 3.11979233 |
99 | cofactor catabolic process (GO:0051187) | 3.10858104 |
100 | plasma lipoprotein particle clearance (GO:0034381) | 3.10852902 |
101 | regulation of protein activation cascade (GO:2000257) | 3.09355774 |
102 | benzene-containing compound metabolic process (GO:0042537) | 3.08579618 |
103 | carnitine transport (GO:0015879) | 3.08019298 |
104 | amino-acid betaine transport (GO:0015838) | 3.08019298 |
105 | exogenous drug catabolic process (GO:0042738) | 3.07442136 |
106 | heme transport (GO:0015886) | 3.05177747 |
107 | glycine metabolic process (GO:0006544) | 3.04955699 |
108 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.04593093 |
109 | carnitine transmembrane transport (GO:1902603) | 3.04470176 |
110 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.04415302 |
111 | hexose biosynthetic process (GO:0019319) | 3.03851962 |
112 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.03413817 |
113 | mitochondrial fusion (GO:0008053) | 3.02872874 |
114 | serine family amino acid metabolic process (GO:0009069) | 3.01279013 |
115 | amino sugar catabolic process (GO:0046348) | 2.96593731 |
116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.96517026 |
117 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.95479575 |
118 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95226379 |
119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95226379 |
120 | cholesterol efflux (GO:0033344) | 2.94782190 |
121 | arginine metabolic process (GO:0006525) | 2.94675265 |
122 | lipopolysaccharide metabolic process (GO:0008653) | 2.89921486 |
123 | ceramide catabolic process (GO:0046514) | 2.89376005 |
124 | glucose catabolic process (GO:0006007) | 2.87220037 |
125 | cellular response to arsenic-containing substance (GO:0071243) | 2.87019546 |
126 | membrane lipid catabolic process (GO:0046466) | 2.85893884 |
127 | sphingolipid catabolic process (GO:0030149) | 2.84794310 |
128 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.82475112 |
129 | mitotic nuclear envelope reassembly (GO:0007084) | 2.78400264 |
130 | nuclear envelope reassembly (GO:0031468) | 2.78400264 |
131 | iron-sulfur cluster assembly (GO:0016226) | 2.77565380 |
132 | metallo-sulfur cluster assembly (GO:0031163) | 2.77565380 |
133 | cellular copper ion homeostasis (GO:0006878) | 2.74238413 |
134 | protein deneddylation (GO:0000338) | 2.71682555 |
135 | skin morphogenesis (GO:0043589) | 2.69078016 |
136 | proline biosynthetic process (GO:0006561) | 2.66360146 |
137 | regulation of superoxide anion generation (GO:0032928) | 2.64797266 |
138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.62913109 |
139 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61807023 |
140 | monosaccharide biosynthetic process (GO:0046364) | 2.61514967 |
141 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.60767674 |
142 | GDP-mannose metabolic process (GO:0019673) | 2.59995509 |
143 | oligosaccharide catabolic process (GO:0009313) | 2.59623969 |
144 | stress fiber assembly (GO:0043149) | 2.58243018 |
145 | glucose 6-phosphate metabolic process (GO:0051156) | 2.56050374 |
146 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.52288364 |
147 | histone arginine methylation (GO:0034969) | 2.51734065 |
148 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.50746720 |
149 | response to peptidoglycan (GO:0032494) | 2.49680842 |
150 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.49293014 |
151 | protein hydroxylation (GO:0018126) | 2.48533656 |
152 | peptidyl-proline hydroxylation (GO:0019511) | 2.46664831 |
153 | hyaluronan catabolic process (GO:0030214) | 2.46308022 |
154 | serine transport (GO:0032329) | 2.45849415 |
155 | amyloid precursor protein metabolic process (GO:0042982) | 2.45800520 |
156 | glycolytic process (GO:0006096) | 2.45358205 |
157 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43270120 |
158 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43182247 |
159 | NIK/NF-kappaB signaling (GO:0038061) | 2.42815362 |
160 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41654698 |
161 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.41588270 |
162 | positive regulation of nuclease activity (GO:0032075) | 2.38861216 |
163 | regulation of metalloenzyme activity (GO:0048552) | 2.37610520 |
164 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.36763020 |
165 | response to thyroid hormone (GO:0097066) | 2.35350577 |
166 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.35162052 |
167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33207058 |
168 | vesicle coating (GO:0006901) | 2.32487872 |
169 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32458219 |
170 | pyrimidine-containing compound salvage (GO:0008655) | 2.32359401 |
171 | pyrimidine nucleoside salvage (GO:0043097) | 2.32359401 |
172 | cell adhesion mediated by integrin (GO:0033627) | 2.31216647 |
173 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30931942 |
174 | hemidesmosome assembly (GO:0031581) | 2.30866748 |
175 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.30402507 |
176 | peptidyl-arginine N-methylation (GO:0035246) | 2.30158751 |
177 | peptidyl-arginine methylation (GO:0018216) | 2.30158751 |
178 | heme biosynthetic process (GO:0006783) | 2.30005018 |
179 | membrane protein ectodomain proteolysis (GO:0006509) | 2.28661409 |
180 | tricarboxylic acid metabolic process (GO:0072350) | 2.28555981 |
181 | proteasome assembly (GO:0043248) | 2.27512865 |
182 | cellular response to unfolded protein (GO:0034620) | 2.27134101 |
183 | negative regulation of cell size (GO:0045792) | 2.26742780 |
184 | ER-nucleus signaling pathway (GO:0006984) | 2.25632690 |
185 | * negative regulation of mitochondrion organization (GO:0010823) | 2.24964840 |
186 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.24671755 |
187 | basement membrane organization (GO:0071711) | 2.24122399 |
188 | heme metabolic process (GO:0042168) | 2.22727932 |
189 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.20433919 |
190 | maintenance of protein localization in organelle (GO:0072595) | 2.20133944 |
191 | cellular response to topologically incorrect protein (GO:0035967) | 2.19400280 |
192 | membrane raft organization (GO:0031579) | 2.17554800 |
193 | response to muramyl dipeptide (GO:0032495) | 2.16825366 |
194 | immunoglobulin mediated immune response (GO:0016064) | 2.16759432 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.34499985 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.82576692 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.38628758 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.35063410 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.54611997 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.32480579 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.77347344 |
8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.20041597 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.10868685 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.04686975 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93435835 |
12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.67959757 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52069104 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46163123 |
15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30426490 |
16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.26971527 |
17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26809837 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19229126 |
19 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16141067 |
20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.13063740 |
21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11083410 |
22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07271049 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00280961 |
24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85001704 |
25 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83872233 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83680704 |
27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.81570308 |
28 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.79106494 |
29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.78402341 |
30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76687920 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73094878 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72218133 |
33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71832315 |
34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.70049250 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63775868 |
36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62995885 |
37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.62278494 |
38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.62147193 |
39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59931845 |
40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.57607805 |
41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56522367 |
42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54897811 |
43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54649857 |
44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.49564653 |
45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45883964 |
46 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45408636 |
47 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43670541 |
48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43505760 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41254543 |
50 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41092157 |
51 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41022445 |
52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39665852 |
53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.39593181 |
54 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38394652 |
55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37215142 |
56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36034815 |
57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35742086 |
58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.35439722 |
59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34726959 |
60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34679151 |
61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33086341 |
62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33037711 |
63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33032806 |
64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32984754 |
65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32834034 |
66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32092168 |
67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.31684838 |
68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30576523 |
69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27132666 |
70 | MYC_22102868_ChIP-Seq_BL_Human | 1.26496079 |
71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25821894 |
72 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.25528139 |
73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24584410 |
74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24251332 |
75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23268997 |
76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23250240 |
77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23086327 |
78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22653662 |
79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22425327 |
80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22220046 |
81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21349869 |
82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21308336 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20526110 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20013538 |
85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19855543 |
86 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19735644 |
87 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19716268 |
88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19538340 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18795707 |
90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18155471 |
91 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17843215 |
92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17048560 |
93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16845162 |
94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15494868 |
95 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15432621 |
96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15359276 |
97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15004823 |
98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14738781 |
99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.14716093 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14658287 |
101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14101653 |
102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13770849 |
103 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.13423746 |
104 | * MAF_26560356_Chip-Seq_TH1_Human | 1.12557106 |
105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10194782 |
106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10017565 |
107 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10009037 |
108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09374118 |
109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08459974 |
110 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.08195401 |
111 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07366908 |
112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06804606 |
113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06626374 |
114 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06454085 |
115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06418567 |
116 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05417208 |
117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05025178 |
118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04474513 |
119 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04227579 |
120 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03902579 |
121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03398939 |
122 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01691254 |
123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01437004 |
124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97805903 |
125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96459199 |
126 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95970275 |
127 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.94807442 |
128 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94680548 |
129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93419438 |
130 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92684355 |
131 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90706917 |
132 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.90655881 |
133 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89134016 |
134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87528032 |
135 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86866503 |
136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85754844 |
137 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85672635 |
138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84308029 |
139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84201892 |
140 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.82513016 |
141 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.82496450 |
142 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82458637 |
143 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82116627 |
144 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81818866 |
145 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80445713 |
146 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78522987 |
147 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76790615 |
148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76545131 |
149 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.76488329 |
150 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.76102658 |
151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75796455 |
152 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.75649637 |
153 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75379817 |
154 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74674707 |
155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74614554 |
156 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.74422932 |
157 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74244980 |
158 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73869804 |
159 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.73724284 |
160 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73482353 |
161 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73089913 |
162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72557734 |
163 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71554226 |
164 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.71292053 |
165 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.70420779 |
166 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.70409880 |
167 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.70398273 |
168 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.69994634 |
169 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69853021 |
170 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.68753274 |
171 | ERA_21632823_ChIP-Seq_H3396_Human | 0.68149691 |
172 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.67390298 |
173 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.66619076 |
174 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.66583176 |
175 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66568203 |
176 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.66236052 |
177 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.66236052 |
178 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.65857996 |
179 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.63986040 |
180 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.63581022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.09219766 |
2 | MP0005360_urolithiasis | 5.66509401 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.83026415 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.17103450 |
5 | MP0005365_abnormal_bile_salt | 4.13688720 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.44482784 |
7 | MP0008260_abnormal_autophagy | 3.41221326 |
8 | MP0009840_abnormal_foam_cell | 3.33842377 |
9 | MP0002837_dystrophic_cardiac_calcinosis | 3.29676656 |
10 | MP0010329_abnormal_lipoprotein_level | 2.88726980 |
11 | MP0003646_muscle_fatigue | 2.88044815 |
12 | MP0005332_abnormal_amino_acid | 2.61052576 |
13 | MP0002822_catalepsy | 2.45713002 |
14 | MP0005083_abnormal_biliary_tract | 2.41117892 |
15 | MP0003195_calcinosis | 2.32293839 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.27284203 |
17 | MP0003252_abnormal_bile_duct | 2.25622313 |
18 | MP0008438_abnormal_cutaneous_collagen | 2.22418846 |
19 | MP0003436_decreased_susceptibility_to | 2.15969647 |
20 | MP0001666_abnormal_nutrient_absorption | 2.14528699 |
21 | MP0002877_abnormal_melanocyte_morpholog | 2.13961837 |
22 | MP0006036_abnormal_mitochondrial_physio | 2.07166684 |
23 | MP0000343_altered_response_to | 1.98973706 |
24 | MP0004130_abnormal_muscle_cell | 1.91504431 |
25 | MP0003075_altered_response_to | 1.89194719 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.87169879 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.86251103 |
28 | MP0005257_abnormal_intraocular_pressure | 1.86028934 |
29 | MP0003172_abnormal_lysosome_physiology | 1.73184118 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.71803455 |
31 | MP0000750_abnormal_muscle_regeneration | 1.71759044 |
32 | MP0005670_abnormal_white_adipose | 1.70392697 |
33 | MP0004043_abnormal_pH_regulation | 1.67935757 |
34 | MP0003566_abnormal_cell_adhesion | 1.67743585 |
35 | MP0006082_CNS_inflammation | 1.65822309 |
36 | MP0000858_altered_metastatic_potential | 1.65714279 |
37 | MP0003828_pulmonary_edema | 1.63780417 |
38 | MP0000609_abnormal_liver_physiology | 1.61323051 |
39 | MP0003724_increased_susceptibility_to | 1.60249776 |
40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59705903 |
41 | MP0003303_peritoneal_inflammation | 1.58099426 |
42 | MP0006035_abnormal_mitochondrial_morpho | 1.57461389 |
43 | MP0000751_myopathy | 1.55291838 |
44 | MP0004272_abnormal_basement_membrane | 1.53326825 |
45 | MP0005410_abnormal_fertilization | 1.52456369 |
46 | MP0004036_abnormal_muscle_relaxation | 1.52324398 |
47 | MP0003329_amyloid_beta_deposits | 1.52208819 |
48 | MP0005165_increased_susceptibility_to | 1.51961606 |
49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.47584532 |
50 | MP0004084_abnormal_cardiac_muscle | 1.45338172 |
51 | MP0002419_abnormal_innate_immunity | 1.44262335 |
52 | MP0001542_abnormal_bone_strength | 1.43502983 |
53 | MP0009785_altered_susceptibility_to | 1.43414789 |
54 | MP0002148_abnormal_hypersensitivity_rea | 1.43370576 |
55 | MP0005330_cardiomyopathy | 1.39970264 |
56 | MP0005464_abnormal_platelet_physiology | 1.39194217 |
57 | MP0009278_abnormal_bone_marrow | 1.37835215 |
58 | MP0004510_myositis | 1.36128788 |
59 | MP0001764_abnormal_homeostasis | 1.31790921 |
60 | MP0001849_ear_inflammation | 1.31736534 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.31569456 |
62 | MP0009643_abnormal_urine_homeostasis | 1.30904188 |
63 | MP0001545_abnormal_hematopoietic_system | 1.28710547 |
64 | MP0005397_hematopoietic_system_phenotyp | 1.28710547 |
65 | MP0004215_abnormal_myocardial_fiber | 1.28372446 |
66 | MP0003300_gastrointestinal_ulcer | 1.27476884 |
67 | MP0000604_amyloidosis | 1.25437146 |
68 | MP0001533_abnormal_skeleton_physiology | 1.24740537 |
69 | MP0002060_abnormal_skin_morphology | 1.23278078 |
70 | MP0002269_muscular_atrophy | 1.22900871 |
71 | MP0000749_muscle_degeneration | 1.22557013 |
72 | MP0009333_abnormal_splenocyte_physiolog | 1.22464922 |
73 | MP0005000_abnormal_immune_tolerance | 1.20321035 |
74 | MP0005025_abnormal_response_to | 1.19941854 |
75 | MP0003283_abnormal_digestive_organ | 1.19105416 |
76 | MP0005535_abnormal_body_temperature | 1.18552947 |
77 | MP0003448_altered_tumor_morphology | 1.18014869 |
78 | MP0000465_gastrointestinal_hemorrhage | 1.16112962 |
79 | MP0000759_abnormal_skeletal_muscle | 1.15427382 |
80 | MP0005636_abnormal_mineral_homeostasis | 1.15402371 |
81 | MP0005451_abnormal_body_composition | 1.13742444 |
82 | MP0006054_spinal_hemorrhage | 1.12304716 |
83 | MP0003453_abnormal_keratinocyte_physiol | 1.10768349 |
84 | MP0004947_skin_inflammation | 1.10561473 |
85 | MP0005023_abnormal_wound_healing | 1.10361628 |
86 | MP0010234_abnormal_vibrissa_follicle | 1.08107878 |
87 | MP0005166_decreased_susceptibility_to | 1.07781407 |
88 | MP0004859_abnormal_synaptic_plasticity | 1.07345017 |
89 | MP0005266_abnormal_metabolism | 1.05897827 |
90 | MP0009046_muscle_twitch | 1.03016185 |
91 | MP0002332_abnormal_exercise_endurance | 1.02739672 |
92 | MP0002909_abnormal_adrenal_gland | 1.02575936 |
93 | MP0008469_abnormal_protein_level | 1.02286363 |
94 | MP0001756_abnormal_urination | 1.01573285 |
95 | MP0002078_abnormal_glucose_homeostasis | 1.00647229 |
96 | MP0008007_abnormal_cellular_replicative | 1.00144628 |
97 | MP0009764_decreased_sensitivity_to | 0.99834902 |
98 | MP0001243_abnormal_dermal_layer | 0.99547085 |
99 | MP0001853_heart_inflammation | 0.99332080 |
100 | MP0002971_abnormal_brown_adipose | 0.97062565 |
101 | MP0001915_intracranial_hemorrhage | 0.97013299 |
102 | MP0003186_abnormal_redox_activity | 0.96815915 |
103 | MP0005666_abnormal_adipose_tissue | 0.96507044 |
104 | MP0002736_abnormal_nociception_after | 0.94427532 |
105 | MP0001765_abnormal_ion_homeostasis | 0.94334400 |
106 | MP0004147_increased_porphyrin_level | 0.93771846 |
107 | MP0002876_abnormal_thyroid_physiology | 0.92864065 |
108 | MP0001845_abnormal_inflammatory_respons | 0.92757227 |
109 | MP0002723_abnormal_immune_serum | 0.92099043 |
110 | MP0002998_abnormal_bone_remodeling | 0.92027627 |
111 | MP0003111_abnormal_nucleus_morphology | 0.90613331 |
112 | MP0002452_abnormal_antigen_presenting | 0.90345725 |
113 | MP0003091_abnormal_cell_migration | 0.90246568 |
114 | MP0005387_immune_system_phenotype | 0.89758681 |
115 | MP0001790_abnormal_immune_system | 0.89758681 |
116 | MP0003950_abnormal_plasma_membrane | 0.89550691 |
117 | MP0000358_abnormal_cell_content/ | 0.89166687 |
118 | MP0003879_abnormal_hair_cell | 0.88039255 |
119 | MP0005501_abnormal_skin_physiology | 0.86921805 |
120 | MP0004087_abnormal_muscle_fiber | 0.86557996 |
121 | MP0009763_increased_sensitivity_to | 0.86557342 |
122 | MP0005448_abnormal_energy_balance | 0.85691248 |
123 | MP0001440_abnormal_grooming_behavior | 0.85135611 |
124 | MP0005620_abnormal_muscle_contractility | 0.83340749 |
125 | MP0001661_extended_life_span | 0.82418925 |
126 | MP0002972_abnormal_cardiac_muscle | 0.82339597 |
127 | MP0009780_abnormal_chondrocyte_physiolo | 0.82030744 |
128 | MP0003868_abnormal_feces_composition | 0.81820704 |
129 | MP0008961_abnormal_basal_metabolism | 0.81534960 |
130 | MP0005621_abnormal_cell_physiology | 0.81158753 |
131 | MP0004484_altered_response_of | 0.81096995 |
132 | MP0000747_muscle_weakness | 0.80936402 |
133 | MP0008872_abnormal_physiological_respon | 0.80841019 |
134 | MP0008789_abnormal_olfactory_epithelium | 0.80482411 |
135 | MP0003279_aneurysm | 0.80366793 |
136 | MP0002064_seizures | 0.80179931 |
137 | MP0005623_abnormal_meninges_morphology | 0.79820746 |
138 | MP0005164_abnormal_response_to | 0.79517291 |
139 | MP0000003_abnormal_adipose_tissue | 0.79493885 |
140 | MP0009745_abnormal_behavioral_response | 0.76824685 |
141 | MP0005376_homeostasis/metabolism_phenot | 0.76795518 |
142 | MP0010030_abnormal_orbit_morphology | 0.76289039 |
143 | MP0008874_decreased_physiological_sensi | 0.75937337 |
144 | MP0005058_abnormal_lysosome_morphology | 0.75706433 |
145 | MP0009642_abnormal_blood_homeostasis | 0.75438218 |
146 | MP0005390_skeleton_phenotype | 0.75035320 |
147 | MP0001501_abnormal_sleep_pattern | 0.74454316 |
148 | MP0004270_analgesia | 0.74293633 |
149 | MP0002106_abnormal_muscle_physiology | 0.73583678 |
150 | MP0001968_abnormal_touch/_nociception | 0.72920566 |
151 | MP0004233_abnormal_muscle_weight | 0.72743746 |
152 | MP0003705_abnormal_hypodermis_morpholog | 0.71864904 |
153 | MP0001819_abnormal_immune_cell | 0.71573343 |
154 | MP0002138_abnormal_hepatobiliary_system | 0.71287759 |
155 | MP0003635_abnormal_synaptic_transmissio | 0.70560918 |
156 | MP0002420_abnormal_adaptive_immunity | 0.70492371 |
157 | MP0001216_abnormal_epidermal_layer | 0.70451032 |
158 | MP0000685_abnormal_immune_system | 0.69939011 |
159 | MP0002405_respiratory_system_inflammati | 0.69088641 |
160 | MP0003137_abnormal_impulse_conducting | 0.68362753 |
161 | MP0003795_abnormal_bone_structure | 0.68277338 |
162 | MP0003011_delayed_dark_adaptation | 0.68196790 |
163 | MP0005385_cardiovascular_system_phenoty | 0.68024214 |
164 | MP0001544_abnormal_cardiovascular_syste | 0.68024214 |
165 | MP0000598_abnormal_liver_morphology | 0.67964923 |
166 | MP0006138_congestive_heart_failure | 0.66038854 |
167 | MP0004085_abnormal_heartbeat | 0.64012518 |
168 | MP0000230_abnormal_systemic_arterial | 0.63949987 |
169 | MP0009697_abnormal_copulation | 0.61753828 |
170 | MP0004142_abnormal_muscle_tone | 0.61504993 |
171 | MP0005334_abnormal_fat_pad | 0.60044445 |
172 | MP0003953_abnormal_hormone_level | 0.59962406 |
173 | MP0005167_abnormal_blood-brain_barrier | 0.59235857 |
174 | MP0008775_abnormal_heart_ventricle | 0.56772676 |
175 | MP0005647_abnormal_sex_gland | 0.55773948 |
176 | MP0002063_abnormal_learning/memory/cond | 0.54497393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.10224789 |
2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.76393487 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.76393487 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.76393487 |
5 | Xanthomatosis (HP:0000991) | 4.34755198 |
6 | Deep venous thrombosis (HP:0002625) | 4.17401549 |
7 | Intrahepatic cholestasis (HP:0001406) | 4.14407962 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.07231267 |
9 | Hyperammonemia (HP:0001987) | 3.98436946 |
10 | Hyperglycinuria (HP:0003108) | 3.94942166 |
11 | Vertebral compression fractures (HP:0002953) | 3.92567221 |
12 | Hyperglycinemia (HP:0002154) | 3.88731533 |
13 | Hypobetalipoproteinemia (HP:0003563) | 3.85394768 |
14 | Ketosis (HP:0001946) | 3.79185892 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.78913220 |
16 | Abnormality of glycine metabolism (HP:0010895) | 3.59101203 |
17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59101203 |
18 | Loss of speech (HP:0002371) | 3.52279242 |
19 | Cerebral edema (HP:0002181) | 3.37359748 |
20 | Vacuolated lymphocytes (HP:0001922) | 3.36868919 |
21 | Gout (HP:0001997) | 3.33363994 |
22 | Prolonged partial thromboplastin time (HP:0003645) | 3.26714765 |
23 | Distal lower limb muscle weakness (HP:0009053) | 3.18877764 |
24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.18244222 |
25 | Dicarboxylic aciduria (HP:0003215) | 3.18244222 |
26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.16211670 |
27 | Ketoacidosis (HP:0001993) | 3.11902883 |
28 | Hypolipoproteinemia (HP:0010981) | 3.11521632 |
29 | Acute encephalopathy (HP:0006846) | 3.10105063 |
30 | Hepatic necrosis (HP:0002605) | 3.09318035 |
31 | Lethargy (HP:0001254) | 3.07655580 |
32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06891571 |
33 | Premature rupture of membranes (HP:0001788) | 3.06261155 |
34 | Abnormal gallbladder physiology (HP:0012438) | 3.05701979 |
35 | Cholecystitis (HP:0001082) | 3.05701979 |
36 | Exercise-induced myalgia (HP:0003738) | 3.02039316 |
37 | Hypoglycemic coma (HP:0001325) | 2.99398911 |
38 | Myoglobinuria (HP:0002913) | 2.96404768 |
39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.96132308 |
40 | Increased connective tissue (HP:0009025) | 2.95993639 |
41 | Axonal loss (HP:0003447) | 2.95734655 |
42 | Hypoalphalipoproteinemia (HP:0003233) | 2.91210662 |
43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.83707009 |
44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.82179928 |
45 | Hepatocellular necrosis (HP:0001404) | 2.80578309 |
46 | Cholelithiasis (HP:0001081) | 2.80491434 |
47 | Sudden death (HP:0001699) | 2.76896342 |
48 | Complement deficiency (HP:0004431) | 2.76251514 |
49 | Increased cerebral lipofuscin (HP:0011813) | 2.74191644 |
50 | Nemaline bodies (HP:0003798) | 2.72651448 |
51 | Dysostosis multiplex (HP:0000943) | 2.71215095 |
52 | Difficulty climbing stairs (HP:0003551) | 2.70270511 |
53 | Abnormal gallbladder morphology (HP:0012437) | 2.69810552 |
54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.67919679 |
55 | Increased muscle lipid content (HP:0009058) | 2.66561095 |
56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66144717 |
57 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.64845737 |
58 | Distal upper limb amyotrophy (HP:0007149) | 2.64117259 |
59 | Upper limb amyotrophy (HP:0009129) | 2.64117259 |
60 | Metabolic acidosis (HP:0001942) | 2.61434859 |
61 | Acute necrotizing encephalopathy (HP:0006965) | 2.60912429 |
62 | Hyperventilation (HP:0002883) | 2.59059400 |
63 | Distal lower limb amyotrophy (HP:0008944) | 2.58034042 |
64 | Muscle fiber inclusion bodies (HP:0100299) | 2.57697772 |
65 | Achilles tendon contracture (HP:0001771) | 2.57467115 |
66 | Prolonged neonatal jaundice (HP:0006579) | 2.57400678 |
67 | Abnormality of serum amino acid levels (HP:0003112) | 2.56899624 |
68 | Hypokinesia (HP:0002375) | 2.54682286 |
69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53998958 |
70 | Pheochromocytoma (HP:0002666) | 2.49861144 |
71 | Hand muscle atrophy (HP:0009130) | 2.49485078 |
72 | Mitochondrial inheritance (HP:0001427) | 2.48614999 |
73 | Hypercholesterolemia (HP:0003124) | 2.46929585 |
74 | Lactic acidosis (HP:0003128) | 2.44956502 |
75 | Exercise-induced muscle cramps (HP:0003710) | 2.42095106 |
76 | Systemic lupus erythematosus (HP:0002725) | 2.41695120 |
77 | Increased CSF lactate (HP:0002490) | 2.40891388 |
78 | Rhabdomyolysis (HP:0003201) | 2.40086101 |
79 | Abnormality of purine metabolism (HP:0004352) | 2.39003469 |
80 | Abnormality of macrophages (HP:0004311) | 2.37726018 |
81 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37425537 |
82 | Abnormality of methionine metabolism (HP:0010901) | 2.37247376 |
83 | Epidermoid cyst (HP:0200040) | 2.37236626 |
84 | Progressive neurologic deterioration (HP:0002344) | 2.36828608 |
85 | Neuroendocrine neoplasm (HP:0100634) | 2.36508947 |
86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34961769 |
87 | Vomiting (HP:0002013) | 2.32401203 |
88 | Limb-girdle muscle atrophy (HP:0003797) | 2.29753665 |
89 | Abnormality of the Achilles tendon (HP:0005109) | 2.29415927 |
90 | Spinal rigidity (HP:0003306) | 2.29089635 |
91 | Ragged-red muscle fibers (HP:0003200) | 2.27991844 |
92 | Fat malabsorption (HP:0002630) | 2.27150240 |
93 | Neck muscle weakness (HP:0000467) | 2.26630552 |
94 | Progressive muscle weakness (HP:0003323) | 2.24728966 |
95 | Palpitations (HP:0001962) | 2.24443291 |
96 | Abnormality of glycolysis (HP:0004366) | 2.23569336 |
97 | Increased serum pyruvate (HP:0003542) | 2.23569336 |
98 | Amyloidosis (HP:0011034) | 2.22254939 |
99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21281913 |
100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21281913 |
101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21281913 |
102 | Abnormal cartilage morphology (HP:0002763) | 2.21269800 |
103 | Hyperbilirubinemia (HP:0002904) | 2.20775008 |
104 | CNS demyelination (HP:0007305) | 2.20147112 |
105 | Hepatosplenomegaly (HP:0001433) | 2.18075005 |
106 | Petechiae (HP:0000967) | 2.17756584 |
107 | Generalized amyotrophy (HP:0003700) | 2.17587495 |
108 | Myopathic facies (HP:0002058) | 2.17374142 |
109 | Irritability (HP:0000737) | 2.17143364 |
110 | Apathy (HP:0000741) | 2.16586515 |
111 | Late onset (HP:0003584) | 2.16477092 |
112 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.16097119 |
113 | Joint hemorrhage (HP:0005261) | 2.15949318 |
114 | Shoulder girdle muscle weakness (HP:0003547) | 2.14307381 |
115 | Fatigue (HP:0012378) | 2.14097027 |
116 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.13788517 |
117 | Methylmalonic aciduria (HP:0012120) | 2.12562622 |
118 | Abnormality of the gallbladder (HP:0005264) | 2.11562419 |
119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11516518 |
120 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11308740 |
121 | Rough bone trabeculation (HP:0100670) | 2.11125593 |
122 | Focal motor seizures (HP:0011153) | 2.08715955 |
123 | Increased variability in muscle fiber diameter (HP:0003557) | 2.08713732 |
124 | Progressive macrocephaly (HP:0004481) | 2.05452823 |
125 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05067716 |
126 | Mucopolysacchariduria (HP:0008155) | 2.05067716 |
127 | Diminished motivation (HP:0000745) | 2.04546137 |
128 | Increased purine levels (HP:0004368) | 2.03920784 |
129 | Hyperuricemia (HP:0002149) | 2.03920784 |
130 | Supranuclear gaze palsy (HP:0000605) | 2.03239846 |
131 | Upper motor neuron abnormality (HP:0002127) | 2.02991905 |
132 | Type 1 muscle fiber predominance (HP:0003803) | 2.02650169 |
133 | Glycosuria (HP:0003076) | 2.02537788 |
134 | Abnormality of urine glucose concentration (HP:0011016) | 2.02537788 |
135 | Skin nodule (HP:0200036) | 2.01905918 |
136 | EMG: myopathic abnormalities (HP:0003458) | 2.01620187 |
137 | Status epilepticus (HP:0002133) | 2.00721776 |
138 | Oligomenorrhea (HP:0000876) | 2.00499041 |
139 | Right ventricular cardiomyopathy (HP:0011663) | 2.00239696 |
140 | Asymmetric septal hypertrophy (HP:0001670) | 2.00232802 |
141 | Bulbar palsy (HP:0001283) | 1.99777754 |
142 | Respiratory failure (HP:0002878) | 1.99235321 |
143 | Abnormality of complement system (HP:0005339) | 1.98742742 |
144 | Spontaneous abortion (HP:0005268) | 1.98740688 |
145 | Malnutrition (HP:0004395) | 1.98351109 |
146 | Proximal tubulopathy (HP:0000114) | 1.98210584 |
147 | Muscle fiber splitting (HP:0003555) | 1.98171698 |
148 | Sensorimotor neuropathy (HP:0007141) | 1.97257814 |
149 | Hyporeflexia of lower limbs (HP:0002600) | 1.96669462 |
150 | Ventricular tachycardia (HP:0004756) | 1.96413981 |
151 | Abnormality of the common coagulation pathway (HP:0010990) | 1.95225499 |
152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94857909 |
153 | Atrioventricular block (HP:0001678) | 1.94350555 |
154 | Delayed CNS myelination (HP:0002188) | 1.93420080 |
155 | Atrophic scars (HP:0001075) | 1.91082308 |
156 | Neonatal onset (HP:0003623) | 1.90956131 |
157 | Ventricular fibrillation (HP:0001663) | 1.90498665 |
158 | Abnormality of the lower motor neuron (HP:0002366) | 1.88774855 |
159 | Interstitial pulmonary disease (HP:0006530) | 1.88370061 |
160 | Trismus (HP:0000211) | 1.88313688 |
161 | Entropion (HP:0000621) | 1.87532502 |
162 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86294783 |
163 | Abnormal protein glycosylation (HP:0012346) | 1.86294783 |
164 | Abnormal glycosylation (HP:0012345) | 1.86294783 |
165 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86294783 |
166 | Neoplasm of head and neck (HP:0012288) | 1.85056837 |
167 | Esophageal neoplasm (HP:0100751) | 1.85056837 |
168 | Recurrent abscess formation (HP:0002722) | 1.82755887 |
169 | Purpura (HP:0000979) | 1.81458902 |
170 | Neuronal loss in central nervous system (HP:0002529) | 1.81441127 |
171 | Short nail (HP:0001799) | 1.80630583 |
172 | Type I transferrin isoform profile (HP:0003642) | 1.80331965 |
173 | Reduced antithrombin III activity (HP:0001976) | 1.78934549 |
174 | Fasciculations (HP:0002380) | 1.78285315 |
175 | Protrusio acetabuli (HP:0003179) | 1.77654447 |
176 | Muscle fibrillation (HP:0010546) | 1.77192781 |
177 | Abnormality of the umbilical cord (HP:0010881) | 1.76870238 |
178 | Pelvic girdle muscle weakness (HP:0003749) | 1.76791714 |
179 | Neurofibrillary tangles (HP:0002185) | 1.74966537 |
180 | Tongue fasciculations (HP:0001308) | 1.74955406 |
181 | Myocardial infarction (HP:0001658) | 1.72720664 |
182 | Growth hormone excess (HP:0000845) | 1.72202527 |
183 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70350664 |
184 | Hypertensive crisis (HP:0100735) | 1.69787594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PDK3 | 5.17292521 |
2 | PDK4 | 5.17292521 |
3 | TAOK3 | 5.12365690 |
4 | BCKDK | 4.25400449 |
5 | NME2 | 4.04714926 |
6 | TESK2 | 3.47551503 |
7 | IRAK3 | 3.15459485 |
8 | PDK2 | 3.08033671 |
9 | TRIB3 | 2.61095481 |
10 | PIM2 | 2.60001709 |
11 | TAOK2 | 2.55164955 |
12 | LIMK1 | 2.47601871 |
13 | ARAF | 2.46189108 |
14 | TBK1 | 2.36518180 |
15 | MAP2K4 | 1.87820403 |
16 | PKN2 | 1.85201230 |
17 | NEK1 | 1.81326594 |
18 | MAP3K9 | 1.81182545 |
19 | RIPK1 | 1.78064492 |
20 | PAK4 | 1.75043807 |
21 | PINK1 | 1.71418481 |
22 | DAPK2 | 1.69340700 |
23 | LMTK2 | 1.58653797 |
24 | SIK3 | 1.57718327 |
25 | MST1R | 1.50033125 |
26 | BUB1 | 1.49696502 |
27 | AKT3 | 1.42902587 |
28 | STK16 | 1.40596890 |
29 | TTN | 1.38191662 |
30 | PHKG1 | 1.35982453 |
31 | PHKG2 | 1.35982453 |
32 | PBK | 1.35765054 |
33 | MAP3K14 | 1.33179817 |
34 | SIK1 | 1.30372140 |
35 | MYLK | 1.30144035 |
36 | SCYL2 | 1.29871445 |
37 | EPHA4 | 1.29107600 |
38 | SMG1 | 1.28779004 |
39 | EPHB1 | 1.27925395 |
40 | VRK2 | 1.25890191 |
41 | EPHB2 | 1.25257606 |
42 | MAP3K4 | 1.24607575 |
43 | BRAF | 1.22291610 |
44 | KSR2 | 1.20588782 |
45 | OBSCN | 1.20125281 |
46 | ERBB4 | 1.17935229 |
47 | NME1 | 1.17868766 |
48 | MAP2K2 | 1.17551908 |
49 | FGFR4 | 1.13268807 |
50 | KDR | 1.13110681 |
51 | WNK4 | 1.13051304 |
52 | STK10 | 1.12093574 |
53 | TGFBR2 | 1.11609106 |
54 | GRK6 | 1.11398846 |
55 | ERN1 | 1.09493441 |
56 | DDR2 | 1.09197237 |
57 | MOS | 1.09155959 |
58 | MAP3K7 | 1.08980908 |
59 | MUSK | 1.07221533 |
60 | PTK2B | 1.06553382 |
61 | DAPK3 | 1.05567289 |
62 | GRK5 | 1.04888368 |
63 | MAP3K11 | 1.02981996 |
64 | MAP3K2 | 0.97544675 |
65 | ICK | 0.97394931 |
66 | TRIM28 | 0.97121639 |
67 | TAOK1 | 0.96898775 |
68 | CAMK2G | 0.95121348 |
69 | MAPKAPK3 | 0.90099116 |
70 | MAP3K12 | 0.86730816 |
71 | PDPK1 | 0.84630501 |
72 | CASK | 0.84311814 |
73 | STK38 | 0.83873675 |
74 | MAP3K8 | 0.82879542 |
75 | PDK1 | 0.81982810 |
76 | GRK7 | 0.81358910 |
77 | MATK | 0.80748536 |
78 | TYK2 | 0.80508858 |
79 | IKBKB | 0.80295054 |
80 | PRKG2 | 0.77393571 |
81 | MAP3K1 | 0.77287967 |
82 | RAF1 | 0.77101625 |
83 | IKBKE | 0.76732041 |
84 | DAPK1 | 0.74988983 |
85 | SGK223 | 0.74320619 |
86 | SGK494 | 0.74320619 |
87 | DYRK1B | 0.73453005 |
88 | EIF2AK1 | 0.73270068 |
89 | PTK2 | 0.73081214 |
90 | PRKD3 | 0.72524502 |
91 | TSSK6 | 0.71552266 |
92 | MAP2K6 | 0.70244842 |
93 | ZAP70 | 0.68648479 |
94 | CSNK1G3 | 0.68593579 |
95 | NTRK3 | 0.67012686 |
96 | ABL2 | 0.66200378 |
97 | MAPK12 | 0.65441610 |
98 | IRAK4 | 0.65012312 |
99 | MAP2K1 | 0.64287065 |
100 | PAK1 | 0.63478713 |
101 | CAMKK1 | 0.63426006 |
102 | MAP2K7 | 0.63089601 |
103 | PAK6 | 0.61404286 |
104 | MAPK11 | 0.61350389 |
105 | PRKD2 | 0.60189222 |
106 | CSK | 0.60124553 |
107 | PRKCG | 0.59264270 |
108 | CAMK2D | 0.58169321 |
109 | PRKAA1 | 0.57554980 |
110 | PRKAA2 | 0.57185597 |
111 | EPHA2 | 0.56954347 |
112 | CAMK2A | 0.56180401 |
113 | MAP3K13 | 0.55464941 |
114 | RPS6KA2 | 0.54212017 |
115 | CDC42BPA | 0.53550642 |
116 | RIPK4 | 0.53543808 |
117 | AKT2 | 0.53170127 |
118 | SGK3 | 0.52639371 |
119 | PIK3CA | 0.51955575 |
120 | PRKACG | 0.51077209 |
121 | PTK6 | 0.50273368 |
122 | TESK1 | 0.49842500 |
123 | MAPKAPK2 | 0.48825059 |
124 | MAP3K3 | 0.48655371 |
125 | AURKA | 0.48189924 |
126 | FGR | 0.47532645 |
127 | CAMK4 | 0.46864263 |
128 | TXK | 0.45251872 |
129 | CSNK1A1L | 0.45167350 |
130 | RPS6KC1 | 0.45070901 |
131 | RPS6KL1 | 0.45070901 |
132 | JAK3 | 0.44522718 |
133 | LATS2 | 0.43978026 |
134 | EIF2AK3 | 0.42427532 |
135 | BMX | 0.41212534 |
136 | JAK2 | 0.40465239 |
137 | OXSR1 | 0.40201612 |
138 | SGK2 | 0.39341278 |
139 | PRKCZ | 0.39132587 |
140 | BLK | 0.38536448 |
141 | CCNB1 | 0.38491948 |
142 | NTRK1 | 0.38309264 |
143 | CAMK2B | 0.38189000 |
144 | GSK3A | 0.38155403 |
145 | INSRR | 0.36657740 |
146 | STK11 | 0.35985369 |
147 | IRAK2 | 0.35597021 |
148 | ROCK2 | 0.34263189 |
149 | MINK1 | 0.33886724 |
150 | CDK14 | 0.32166639 |
151 | PDGFRA | 0.32109350 |
152 | DYRK3 | 0.31320950 |
153 | CDK5 | 0.31307366 |
154 | MAPK4 | 0.31290941 |
155 | FER | 0.30348223 |
156 | ILK | 0.29784350 |
157 | NEK9 | 0.29744433 |
158 | MAP2K3 | 0.29327915 |
159 | CDK19 | 0.27996609 |
160 | PRPF4B | 0.27385830 |
161 | MAP3K5 | 0.27222899 |
162 | PRKACA | 0.26955079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.00929846 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.60263770 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.10977423 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.96815204 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.85344705 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81577821 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60282852 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58960094 |
9 | Lysosome_Homo sapiens_hsa04142 | 2.50493897 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48719142 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.44102765 |
12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.34934019 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33658874 |
14 | Proteasome_Homo sapiens_hsa03050 | 2.33474404 |
15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.33327249 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32881948 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.26416327 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07818490 |
19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.05145035 |
20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04141688 |
21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.96310479 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95698296 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76697045 |
24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75807000 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74140304 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68560261 |
27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65869802 |
28 | Peroxisome_Homo sapiens_hsa04146 | 1.64121885 |
29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59549288 |
30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53605045 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53468691 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53000125 |
33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52734316 |
34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.51638539 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.51410956 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.50494727 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48893653 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45607927 |
39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44925878 |
40 | Legionellosis_Homo sapiens_hsa05134 | 1.44031558 |
41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41778166 |
42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39532284 |
43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38169432 |
44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.37461324 |
45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36002257 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31667206 |
47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30114414 |
48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28343661 |
49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.28340527 |
50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26545513 |
51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26448897 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 1.26105995 |
53 | Bladder cancer_Homo sapiens_hsa05219 | 1.24649464 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23005767 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22174094 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18431128 |
57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18108664 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17767519 |
59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14358983 |
60 | Pertussis_Homo sapiens_hsa05133 | 1.11943953 |
61 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11891691 |
62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11777613 |
63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11638239 |
64 | Phagosome_Homo sapiens_hsa04145 | 1.10490744 |
65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09781955 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08649897 |
67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08115513 |
68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07703393 |
69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07326628 |
70 | Base excision repair_Homo sapiens_hsa03410 | 1.06453196 |
71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06343906 |
72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04948220 |
73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03085263 |
74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01867348 |
75 | Apoptosis_Homo sapiens_hsa04210 | 1.01130180 |
76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99333671 |
77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97500851 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96184663 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94576417 |
80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92247496 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92118250 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92058727 |
83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91391299 |
84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90206491 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89504013 |
86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89362694 |
87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88930726 |
88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86868300 |
89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84129804 |
90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84010825 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80927978 |
92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80819684 |
93 | Tuberculosis_Homo sapiens_hsa05152 | 0.80283631 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79923397 |
95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79419657 |
96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78417882 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.77200162 |
98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77069955 |
99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74620021 |
100 | ABC transporters_Homo sapiens_hsa02010 | 0.74458748 |
101 | Malaria_Homo sapiens_hsa05144 | 0.73898197 |
102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72524827 |
103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70745319 |
104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70267904 |
105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69442867 |
106 | Influenza A_Homo sapiens_hsa05164 | 0.69068963 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.68972234 |
108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66502354 |
109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66120657 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62430557 |
111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62354832 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60849823 |
113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59173597 |
114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58147913 |
115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58020205 |
116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57000386 |
117 | DNA replication_Homo sapiens_hsa03030 | 0.56955412 |
118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56196536 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55994262 |
120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55926944 |
121 | Hepatitis C_Homo sapiens_hsa05160 | 0.55370736 |
122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55204116 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54768497 |
124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54716127 |
125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53236760 |
126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52997653 |
127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49058491 |
128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46184085 |
129 | Measles_Homo sapiens_hsa05162 | 0.46120169 |
130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46064631 |
131 | Amoebiasis_Homo sapiens_hsa05146 | 0.45758376 |
132 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44771335 |
133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43724290 |
134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43544182 |
135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39836506 |
136 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.38978764 |
137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38136052 |
138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36437092 |
139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36340089 |
140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33380707 |
141 | Spliceosome_Homo sapiens_hsa03040 | 0.32962007 |
142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32864262 |
143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32472976 |
144 | Insulin resistance_Homo sapiens_hsa04931 | 0.31567153 |
145 | Prion diseases_Homo sapiens_hsa05020 | 0.26807043 |
146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26629412 |
147 | Lysine degradation_Homo sapiens_hsa00310 | 0.23934949 |
148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23550782 |
149 | Mineral absorption_Homo sapiens_hsa04978 | 0.22271574 |
150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21921323 |
151 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21295816 |
152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20775004 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20207958 |
154 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19614241 |
155 | Insulin secretion_Homo sapiens_hsa04911 | 0.15709531 |
156 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.15352675 |
157 | Salivary secretion_Homo sapiens_hsa04970 | 0.15207480 |
158 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13811140 |
159 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13159603 |
160 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.12665558 |
161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10218139 |
162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07259227 |
163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.05686475 |
164 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05408150 |